Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01

Known as: FF-10501, FF-10501-01, IMPDH Inhibitor FF-10501 
An orally bioavailable inhibitor of inosine 5'- monophosphate dehydrogenase (IMPDH), with potential antineoplastic activity. Upon administration… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
FF-10501-01 potently inhibits inosine-5-monophosphate dehydrogenase (IMPDH), inducing anti-proliferative and pro-apoptotic… Expand
Is this relevant?
2018
2018
Abstract One of the major symptoms of myelodysplastic syndromes (MDS) is severe cytopenia. Despite cytokine therapies, such as… Expand
Is this relevant?
Review
2018
Review
2018
Introduction FF-10501-01 is an orally bioavailable potent inhibitor of inosine-5-monophosphate dehydrogenase (IMPDH). In vitro… Expand
Is this relevant?
2017
2017
BACKGROUND FF-10501-01 is a selective inosine monophosphate dehydrogenase (IMPDH) inhibitor that has shown activity in cancer… Expand
Is this relevant?
2016
2016
Abstract Resistance to azacitidine is a major issue in the treatments of myelodysplastic syndrome and acute myeloid leukemia, and… Expand
  • table 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
Is this relevant?
2016
2016
Uncontrolled cell proliferation is a hallmark of cancer and requires adequate nucleotide biosynthesis. Inosine monophosphate… Expand
Is this relevant?
2016
2016
Introduction Inosine 59- monophosphate dehydrogenase (IMPDH) plays a critical role in nucleotide synthesis by serving as a rate… Expand
Is this relevant?
2015
2015
Inosine 59- monophosphate dehydrogenase (IMPDH) is a rate-limiting enzyme that catalyzes de novo synthesis of the guanine… Expand
Is this relevant?
2015
2015
Inosine 59- monophosphate dehydrogenase (IMPDH) is a rate-limiting enzyme that catalyzes de novo synthesis of the guanine… Expand
Is this relevant?
Review
2015
Review
2015
Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders, characterized by peripheral blood cytopenia and… Expand
Is this relevant?